I am a radiologist who specializes in body imaging. My expertise is in imaging for liver cancer, bile duct cancer, and pancreatic cancer. I help oncologists make the best decisions possible for treating hepatopancreatobiliary cancers. From diagnosis and staging to treatment response, I am committed to delivering accurate and actionable reports for the care of people with cancer. While I have been practicing at MSK for nearly a decade, my goal is to continuously improve diagnosis and treatment through active research.
Read more Read less
My research interests are in advanced CT and MRI techniques for hepatopancreatobiliary tumors. I also work with computer scientists to investigate the potential of computer-based medical image analysis. This approach, also known as radiomics, lets us look at medical images beyond what the human eye can see. Medical images contain a vast amount of hidden data. We are harnessing this big data to predict tumor pathology, genetics, and response to treatment.
I am active in the American College of Radiology. Together with other radiologists, I am developing new guidelines for treatment response assessment for hepatocellular carcinoma and other liver tumors. I frequently lecture on hepatopancreatobiliary tumors at meetings for the Radiological Society of North America and the International Society for Magnetic Resonance in Medicine. Finally, as MRI Safety Officer at MSK, I lead a team of doctors, nurses, managers, and radiology technologists to ensure the complete safety of people with cancer and staff members in the MRI environment.
- Clinical Expertise: Abdominal Radiology
- Languages Spoken: English
- Education: MD, Weill Cornell Medical College; PhD, Weill Cornell Graduate School of Medical Sciences
- Residencies: NYU Langone Medical Center
- Fellowships: NYU Langone Medical Center
- Board Certifications: Diagnostic Radiology
Sadot E, Simpson AL, Do RK, Gonen M, Shia J, Allen PJ, D’Angelica MI, DeMatteo RP, Kingham TP, Jarnagin WR. Cholangiocarcinoma: Correlation between Molecular Profiling and Imaging Phenotypes. PLoS One. 2015 Jul 24;10(7):e0132953
Simpson AL, Adams LB, Allen PJ, D’Angelica MI, DeMatteo RP, Fong Y, Kingham TP, Leung U, Miga MI, Parada EP, Jarnagin WR, Do RK. Texture analysis of preoperative CT images for prediction of postoperative hepatic insufficiency: a preliminary study. J Am Coll Surg. 2015 Mar;220(3):339-46
Konstantinidis IT, Do RK, Gultekin DH, Gönen M, Schwartz LH, Fong Y, Allen PJ, D’Angelica MI, DeMatteo RP, Klimstra DS, Kemeny NE, Jarnagin WR. Regional chemotherapy for unresectable intrahepatic cholangiocarcinoma: a potential role for dynamic magnetic resonance imaging as an imaging biomarker and a survival update from two prospective clinical trials. Ann Surg Oncol. 2014 Aug;21(8):2675-83
Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.
Read more Read less
Clinical Trials Co-Investigated by Richard Kinh Gian Do
- A Phase I Study of Stereotactic Body Radiotherapy after Chemotherapy for Locally Advanced Inoperable Pancreatic Cancer
- A Phase II Study of Hepatic Arterial Infusion with Floxuridine and Dexamethasone plus Systemic Gemcitabine and Oxaliplatin in Patients with Inoperable Intrahepatic Cholangiocarcinoma
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more